Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 28Carcinoma, Renal Cell 19Melanoma 18Lung Neoplasms 11Squamous Cell Carcinoma of Head and Neck 8Neoplasm Metastasis 8Hodgkin Disease 7Colorectal Neoplasms 7Adenocarcinoma Of Esophagus 7Stomach Neoplasms 6Neoplasms 6Carcinoma, Hepatocellular 6Triple Negative Breast Neoplasms 5Prostatic Neoplasms 5Pancreatic Neoplasms 5Carcinoma, Transitional Cell 5Urinary Bladder Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Nasopharyngeal Carcinoma 4Endometrial Neoplasms 4Carcinoma, Merkel Cell 4Carcinoma, Basal Cell 4Brain Neoplasms 4Anus Neoplasms 4Oropharyngeal Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3

Interventions

Cisplatin 14Magnetic Resonance Spectroscopy 12Specimen Handling 10Platinum 91,2-diaminocyclohexaneplatinum II citrate 9Radiotherapy 7Radiotherapy, Intensity-Modulated 5Radiation 5Carboplatin 5Biopsy 4Taxes 3Surveys and Questionnaires 3Paclitaxel 3Nivolumab 3pembrolizumab 2Radiotherapy, Image-Guided 2Observation 2Fluorodeoxyglucose F18 2Docetaxel 2Chemoradiotherapy 2Cetuximab 2(225)Ac-DOTA-c(RGDyK) 2merphos 1ipatasertib 1durvalumab 1dehydroftorafur 1cemiplimab 1cabozantinib 1balstilimab 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Nivolumab × 30 days × Clear all
NCT05136196 2026-05-19

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

National Cancer Institute (NCI)

Phase 2 Recruiting
150 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT03811015 2026-05-13

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
636 enrolled
Head & Neck

Oropharyngeal Neoplasms

NCT03952585 2026-05-04

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
384 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡